Niaspan tops Zetia in new setback for Merck drug | Reuters
Links shared publicly online about this topic.
- 1,600total visits
Niaspan tops Zetia in new setback for Merck drug | Reuters
View full resource at reuters.com
Tags: Circulation, Cholesterol Medication, Drug, Zetia, Niaspan, Merck & Co.
Most Recently Shared on November 15, 2009 at 11:13 pm By:
Niaspan tops Zetia in new setback for Merck drug - Reuters http://bit.ly/1A1zvP
RPT-UPDATE 3-Niaspan tops Zetia in new setback for Merck drug | Reuters
reuters.com — “* Niaspan leads to reduction in artery wall thickness * No meaningful change seen with Zetia * 5 times as many serious adverse events seen with Zetia * Journal editorials cite several limitations” View full resource at reuters.com
Most Recently Shared on November 16, 2009 at 2:31 pm By:
RPT-UPDATE 3-Niaspan tops Zetia in new setback for Merck drug - Reuters http://ow.ly/1621xi
UPDATE 3-Niaspan tops Zetia in new setback for Merck drug | Reuters
reuters.com — “* Niaspan leads to reduction in artery wall thickness * No meaningful change seen with Zetia * 5 times as many serious adverse events seen with Zetia * Journal editorials cite several limitations” View full resource at reuters.com
Most Recently Shared on November 16, 2009 at 2:27 am By:
UPDATE 3-Niaspan tops Zetia in new setback for Merck drug - Reuters http://ow.ly/161V5K
UPDATE 2-Niaspan tops Zetia in new setback for Merck drug | Reuters
reuters.com — “* Niaspan leads to reduction in artery wall thickness * No meaningful change seen with Zetia * 5 times as many serious adverse events seen with Zetia * Journal editorials cite several limitations” View full resource at reuters.com
Most Recently Shared on November 16, 2009 at 12:44 am By:
low sodium foods Health Business
UPDATE 2-Niaspan tops Zetia in new setback for Merck drug - Reuters http://bit.ly/oIV29
UPDATE 2-Niaspan tops Zetia in new setback for Merck drug | Reuters
reuters.com — “* Niaspan leads to reduction in artery wall thickness * No meaningful change seen with Zetia * 5 times as many serious adverse events seen with Zetia * Journal editorials cite several limitations” View full resource at reuters.com
Most Recently Shared on November 15, 2009 at 11:39 pm By:
Ben Hirschler Health Communicator
Niaspan vs Zetia trial a blow for Merck's cholesterol business, but maybe not a knock-out one http://tinyurl.com/ylzuy6v #AHA2009
Advertisement
